chartexchange

Scribe Therapeutics Presents New Data Advancing the Potential of Ultra-Long-Acting Genetic Medicines for Cardiovascular Disease at AHA Scientific Sessions 2026

GlobeNewswire Inc. | Nov 18, 2026 8:00 AM EST

Scribe Therapeutics presents new data advancing the potential of ultra-long-acting genetic medicines for cardiovascular disease at AHA Scientific Sessions

Read original article